NCT06391723View on ClinicalTrials.gov

Clinical, Cognitive and Neural Effects of Potentiation of ECT by rTMS in Treatment-Resistant Depression

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions
Major Depressive Disorder
Interventions
DEVICE

Active rTMS

rTMS will be administered over the left dorsolateral prefrontal cortex (20 Hz, 90% resting motor threshold, 20 2 s trains with 60-s intervals, 800 pulses/session)

DEVICE

Sham rTMS

Sham rTMS will be administered over the left dorsolateral prefrontal cortex

All Listed Sponsors
collaborator

University Hospital, Rouen

OTHER

collaborator

Centre Hospitalier Sainte Anne, Paris

UNKNOWN

lead

Centre Hospitalier du Rouvray

OTHER_GOV

NCT06391723 - Clinical, Cognitive and Neural Effects of Potentiation of ECT by rTMS in Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter